Navigation Links
PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
Date:1/15/2014

9.2 Abbreviations 839.3 Methodology 859.4 Forecasting Methodology 859.4.1 Diagnosed Atopic Dermatitis Patients 869.4.2 Percent Drug-treated Patients 869.4.3 Drugs Included in Each Therapeutic Class 879.4.4 General Pricing Assumptions 879.4.5 Individual Drug Assumptions 889.4.6 Generic Erosion 899.5 Physicians and Specialists Included in this Study 909.6 Primary Research - Prescriber Survey 919.7 About the Authors 929.7.1 Author 929.7.2 Global Head of Healthcare 939.8 About GlobalData 949.9 Disclaimer 94

1.1 List of Tables

Table 1: Symptoms of Atopic Dermatitis 19Table 2: Treatment Guidelines for Atopic Dermatitis 25Table 3: Most Prescribed Drugs for Atopic Dermatitis by Severity in the Global Markets, 2013 27Table 4: Referral Rates to an Indian Dermatologist, Split by Severity and Specialist Type, 2013 28Table 5: Key Metrics Relating to the Diagnosis, Relapse and Remission Rates of Atopic Dermatitis in India in 2012 29Table 6: Leading Treatments for Atopic Dermatitis, 2013 33Table 7: Product Profile - Protopic 35Table 8: Clinical Response Data of Protopic (0.03% and 0.1%) versus Vehicle Ointment at Week 12 from One Study in Pediatric Patients and Two Combined Studies in Adult Patients 36Table 9: Protopic SWOT Analysis, 2013 39Table 10: Product Profile - Elidel 41Table 11: Combined Clinical Efficacy Results of Elidel versus Vehicle Cream at Week 6 from Two Phase III Studies 42Table 12: Elidel SWOT Analysis, 2013 45Table 13: Product Profile - Cyclosporine 47Table 14: Cyclosporine SWOT Analysis, 2013 49Table 15: Summary of Other Therapeutic Classes for Atopic Dermatitis, 2013 50Table 16: Overall Unmet Needs in Atopic Dermatitis - Current Level of Attainment 52Table 17: Clinical Unmet Needs in Atopic Dermatitis - Gap Analysis, 2013 59Table 18: Late-Stage Atopic Dermatitis Pipeline, 2013 64Table 19: Comparison of Therapeutic Classes in Development for Atopic Dermatitis, 2013 65Table 20: Phase II and Ph
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
10. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
11. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... and technology platform company serving the pharmaceutical, biotechnology, and ... United States, today announced its financial results for the ... Fourth-Quarter 2014 Highlights , Net Revenues Increased 21.3% ... Services Net Revenues Grew 17.7% Year Over Year to ...
(Date:3/5/2015)... and TÜBINGEN, Germany , ... Melinda Gates Foundation and CureVac today announced that ... $52 million (€46 million) in CureVac, a leading ... As part of the agreement, the foundation will ... develop prophylactic vaccines based on CureVac,s proprietary messenger ...
(Date:3/5/2015)... 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... ended January 31, 2015 on Thursday, March 12 before the ... results at 11:00 AM ET. To participate ... 10 minutes before the beginning of the call. If you ... will be available from Thursday, March 12, 2015 through midnight ...
Breaking Medicine Technology:WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 22The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
... ... Salt Lake City based software company, announces the launch of a new ... in conjunction with existing in-office therapy methods. , eyeQ was ... elect, Dr. Brad Habermehl believes the eyeQ program adds significant ...
... , FRANKLIN, Mass., Nov. 24 ... company developing its needle-free Symphony(TM) tCGM System as a ... its Prelude(TM) SkinPrep System for transdermal drug delivery, announced ... Executive Officer, will present at the 13th Annual Biotech ...
Cached Medicine Technology:Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
(Date:3/6/2015)... March 06, 2015 Parents need to ... reality of substance use disorders. School programs like DARE, ... marginally successful. NOPE, or Narcotics Overdose Prevention and Education ... to Healthline News on Feb. 27th. As ... prescription opiate drugs, drug prevention proponents are lobbying Florida ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... 06, 2015 Further solidifying their position ... Doctor Associates announced today that the company has earned ... the Best of Staffing Talent Award five years in ... of Staffing Talent Diamond winners are proven industry leaders ... them by the individuals they have helped find temporary ...
(Date:3/6/2015)... Cailfornia (PRWEB) March 06, 2015 ... technology company, announced today the launch of its ... money on healthy and sustainable products at any ... Makeena is exhibiting at Expo West Booth 6054. ... search by gluten-free, Kosher, non-GMO, organic, Paleo, and ...
Breaking Medicine News(10 mins):Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3
... group from Bradford's St Luke's Hospital, gauged the cost-benefit of ... hospital into the community, and said that there was no ... ,Indeed cost savings has been the driving force behind the ... studying the costs of rehabilitating 220 senior patients, recouping from ...
... potential economic cost of HIV epidemic could be substantial, says ... costs to the economy arising from the continued and unchecked ... to the report released here Thursday, based on a study ... (NCAER) with the support of state-run National AIDS Control Organisation ...
... A new test for esophageal reflux disease developed by ... been licensed to Bayer HealthCare’s Diagnostics Division by WFUHS.// ... pepsin 3b in a patient’s saliva, was developed by ... Forest University School of Medicine and director of WFUHS’s ...
... influenza virus while plans are in place to vaccinate the ... form of bird flu. Dr. Thonton said that other bird ... avian influenza virus. ,The highly pathogenic bird flu ... the year 2003.It remains difficult for humans to contact the ...
... as a potential provider of artificial blood, indeed considered a ... through our veins, very much our lifeline has always been ... blood during complex surgeries to save the life of the ... in store, and a little worm which is popularly called ...
... has approved the use of Gardasil, cervical cancer vaccine ... use in a national// immunization program. ,The ... of Human Papilloma Virus (HPV) which is a common ... sexually active adults sometime during their life, it is ...
Cached Medicine News:Health News:HIV Epidemic Can Slow Down Economic Growth: UNDP 2Health News:Test for Esophageal Reflux Licensed to Bayer by University 2Health News:A Worm Turns: Banking on Blood From a Little Lugworm 2
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
ROB-NEL Catheters (100% Latex-Free)...
Red Rubber Robinson Catheters (Latex)...
Urethral Red Rubber Catheters (Latex)...
Medicine Products: